Back to search

Article

An integrative RNA spliceosomic landscape of pancreatic neuroendocrine tumors unveils novel clinicomolecular associations

2024-11-03

Abstract excerpt

<h4>ABSTRACT</h4> Alterations in alternative splicing are emerging as a novel hallmark in cancer biology, offering new insights. However, integrative analyses of splicing are still scarce, particularly in rare cancers such as pancreatic neuroendocrine tumors (PanNETs). These tumors are highly heterogeneous, complicating diagnosis and treatment. This study is the first to comprehensively investigate the RNA splici...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c16b5e2-3585-5efd-b6b8-13f9dcc0ef69
DOI
10.1101/2024.10.30.621040
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An integrative RNA spliceosomic landscape of pancreatic neuroendocrine tumors unveils novel clinicomolecular associationsDOI 10.1101/2024.10.30.621040
Spliceosomic dysregulation unveils <i>NOVA1</i> as an actionable therapeutic target in pancreatic neuroendocrine tumorsSemantic proximity
Dysregulation of CELF4 splicing factor in pancreatic neuroendocrine tumors enhances aggressiveness and alters mTOR pathway and everolimus responseSemantic proximity
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus responseSemantic proximity
Molecular Basis of Pancreatic Neuroendocrine TumorsSemantic proximity
A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancerSemantic proximity
Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discoverySemantic proximity
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumorsSemantic proximity
Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discoverySemantic proximity
Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patternsSemantic proximity
Genetic and epigenetic drivers of neuroendocrine tumours (NET)Semantic proximity
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.Semantic proximity
Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms.Semantic proximity
Select a neighboring publication to make it the new centre.